Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/entuCfbwocfExsrZGgwn

  ADVERTISEMENT  
March 18, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
 
  ADVERTISEMENT  
How much do you hate your anti-Fyb?
Tired of sub-par reactions? Quotient has a newly approved anti-Fyb, as well as hard-to-find Anti-s, Anti-Wra and other rare antisera that are worth a try. Find out how the one company focused on manual testing can serve you in 2013 and beyond.

  Science & Health 
 
  • Device to preserve livers for transplant is used successfully in U.K.
    Two British patients became the first to receive donated livers preserved using an automated perfusion system. The device, being developed by Oxford University researchers, keeps the organ functioning outside the body for longer than 24 hours, maintaining it at body temperature and supplying it with oxygenated red blood cells. Reuters (3/15) LinkedInFacebookTwitterEmail this Story
  • NSAIDS may boost the number of cells collected for transplants
    Blocking prostaglandin with nonsteroidal anti-inflammatory drugs helps stem cells leave the bone marrow and enter the bloodstream, where they can be collected for use in therapies, according to a study in the journal Nature. The drugs can be linked to fewer adverse effects compared with other methods, according to researchers, who looked at humans, mice and baboons. Charles Craddock, director of the blood and marrow transplant unit at Queen Elizabeth Hospital in Birmingham, England, said the findings could lead to better methods for integrating the cells with bone marrow in transplant recipients. ScientificAmerican.com/Nature (3/13) LinkedInFacebookTwitterEmail this Story
 
  • Experts: Drug-resistant infections pose wide-ranging threat
    In Australia, four-fifths of urinary tract infections are resistant to more than one antibiotic, according to a report in the Medical Journal of Australia. Infectious disease experts are calling on the nation's government to establish a group to oversee the use of antibiotics. Tissue transplants and critical care are among the areas threatened by the rise of antibiotic-resistant infections, experts said. News.com.au (Australia) (3/18) LinkedInFacebookTwitterEmail this Story
  • Study: Clot-busting drug OK for stroke patients on mild anticoagulants
    Giving tissue plasminogen activator to patients suffering a stroke who have been taking aspirin or the anticoagulant clopidogrel is not likely to cause fatal brain bleeding, a study published in the journal Academic Emergency Medicine found. Researchers examined data from more than 800 tPA-treated stroke patients and found no significant difference in the brain bleeding rate between patients taking clopidogrel or aspirin and those not taking either drug. The findings might not apply to patients taking warfarin, heparin, dabigatran or rivaroxaban, researchers noted. HealthDay News (3/14) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Quality and Process Improvement Solutions are Just a Click Away
AABB Consulting Services can help you meet the requirements of any accrediting organization. Guidance is also available for: implementation plans, process flow, software issues, computer validation, compliance audits, vendor audits and custom projects. For more information, visit our web site or email consulting@aabb.org.

  Hot Topics 

Top five news stories selected by AABB SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Emerging Trends 
  Industry News & Practice 
  • FDA warns Hospira over problems at N.C. plant
    Hospira has received an FDA warning citing 20 issues found at its facility in Rocky Mount, N.C., after a three-week inspection. The company, which develops infusion systems and injectable drugs, said it is cooperating with the FDA regarding the matter and will respond to the findings with a plan for remediation and modernization. MassDevice.com (Boston) (3/14) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

Registration Now Open - April 9, 2013 PACT Workshop
“Developing Cellular Therapies: From Preclinical Safety to Clinical Evaluation”. Hosted by University of Wisconsin, Waisman Biomanufacturing (WB), Madison, WI. No charge for attendance. Click here for more details.


  Government & Regulatory 
  • Iowa is looking at more than 80 compounding pharmacies
    The Iowa Board of Pharmacy began inspecting more than 80 U.S. compounding pharmacies that conduct business in the state. The move is the latest in a series of inspection efforts following a fungal meningitis outbreak that was tied to contaminated steroid injections manufactured by a compounding pharmacy in Framingham, Mass. The board intends to inspect 582 pharmacies that hold Iowa licenses. The Wall Street Journal (3/15) LinkedInFacebookTwitterEmail this Story
  • EHR payments reach $12.3B, CMS reports
    CMS has issued about $12.3 billion in Medicare and Medicaid incentive payments to 219,000 health care providers from the start of the program through last month. "We expect that February number will continue to grow as we process them through the month. We're already seeing some providers come in for 2013," said Robert Anthony of CMS' Office of E-Health Standards and Services. Government Health IT online (3/15) LinkedInFacebookTwitterEmail this Story
  Association News 
  • AABB Center for Cellular Therapies to develop directory of training opportunities
    The AABB Center for Cellular Therapies is seeking contributions to develop a directory of training opportunities. Upon completion, the directory will offer members an extensive list of education programs related to cellular therapy laboratory practice, quality activities, patient care and clinical programs. Organizations providing such opportunities are encouraged to complete the online submission form. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Associate Medical DirectorBloodCenter of WisconsinUS - WI - Milwaukee
Director, Quality (CTS-Chicago)Blood Systems, Inc.US - IL - Rosemont
Director, Community Center IIUnited Blood ServicesUS - SD - Rapid City
Quality SpecialistBlood Systems, Inc.US - AZ - Scottsdale
Quality Specialist (BCP)Blood Systems, Inc.US - CA - San Francisco
Reference Lab TechnologistAmerican Red Cross Blood ServicesUS - CA - Oakland
Supervisor of Blood Donor ServicesBaystate HealthUS - MA - Springfield
Click here to view more job listings.

  SmartQuote 
What men value in this world is not rights but privileges."
--H.L. Mencken,
American journalist and essayist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information